Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accutane Enhanced SMART Program Could Be Applied In Six Months – Roche

Executive Summary

Roche and generic firms could implement a revised isotretinoin (Accutane and generics) risk management program in six months, Roche VP-Drug Safety Risk Management Martin Huber, MD, said

You may also be interested in...



Accutane Update Is First Time For Wholesaler Instructions In A Product Label

A recently approved risk management program to prevent pregnancies in patients taking isotretinoin (Roche's Accutane and generics) includes the unprecedented addition of wholesaler-focused instructions to prescription drug labeling

Accutane Update Is First Time For Wholesaler Instructions In A Product Label

A recently approved risk management program to prevent pregnancies in patients taking isotretinoin (Roche's Accutane and generics) includes the unprecedented addition of wholesaler-focused instructions to prescription drug labeling

SMART-er Isotretinoin Risk Management Program To Be Operated By Covance

Covance will develop and operate a single, enhanced risk management program for all four isotretinoin products

Related Content

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel